According to the current analysis
of Reports and Data, the global Diazepam
market was valued at USD 982.8 million in 2018 and is expected to
reach USD 1.27 billion by the year 2026, at a CAGR of 3.4%. Diazepam is
utilized to calm indications of anxiety and alcohol withdrawal. This medication
is likewise utilized to treat certain seizure problems and help loosen up
muscles or ease muscle spasm. It is a benzodiazepine, which is from the class
of medications known as central nervous system (CNS) depressants, which are
used for the purpose of slowing down the nervous system. However this
medication is strictly available only at doctor’s prescription. It has
applications in the management of anxiety disorders, alcohol withdrawal, muscle
spasms (relaxant), insomnia, and other nervous system associated illnesses. It
is also used for healing panic disorders, or as preoperative sedation and light
anesthesia. Several clinical trials has been conducted to evaluate its potency
& efficacy in pediatric, adult and geriatric population. The rising
prevalence of anxiety disorder, insomnia, psychotic disorders and over
consumption of alcohol are the primary factors that trigger the growth of this
medication industry. However the increasing drug abuse incidences, stringent
regulatory scenarios due to its tendency of people getting addictions and the
side effects of diazepam will hamper the growth of diazepam market.
The most commonly used brand of
diazepam is valium, which has received FDA approval for two formulations,
5mg/ml injection and 2, 5 and 10mg tablets. There are several other clinical
trials of diazepam ongoing such as, for alcohol withdrawal using diazepam
injectable solution, for treatment of febrile seizures, for low back pain,
epilepsy associated sicknesses, and for some other illnesses associated with
infertility, molar surgeries among others.
Furthermore, increasing
investments on clinical trials for multiple applications of this drug,
availability of research funds from private as well as public bodies, some
improvements in the reimbursement scenario, and rising awareness about multiple
uses, least side effects of this drug are among the key factors propelling the
growth of Diazepam market.
To identify the key trends in
the industry, click on the link below:
Further key findings from
the report suggest
- The rectal gel type segment of form of medication is
expected to grow with a CAGR of 3.3% during the forecast period. Tablets
remains the chief revenue generating segment in global Diazepam market.
- Prescription for mental disorders including
depression, anxiety, insomnia, use of diazepam as a light anesthetic, use
of diazepam by veterinarians on dogs to treat seizures, muscle relaxation
and most importantly alcohol withdrawal, are among the key applications of
diazepam contributing to the market growth.
- Diazepam may have some habit forming tendency in the
body, hence is strictly suggested to take only as per the prescription of
doctor. For muscle spasm, it is suggested to take 2-10 mg 3 or 4 times a
day in adults. While in older adults it is prescribed generally to be
taken between 2 to 2.5 mg strength, 1 or 2 times a day. The dose can be
increased or decreased as well by the doctor as per the patient responds
to the drug. In children above the age of 6 months a dose of 1 to 2.5 mg,
3 or 4 times per day is suggested.
- Numerous clinical trials are ongoing in its final
stages to test the effects of diazepam on disorders other than currently
known in the medical industry, such as for treating females patients with
high tone pelvic floor dysfunction, behavioral emergency and acute
agitation, efficacy and safety levels while using to treat Epilepsies,
both partial and complex partial.
- The global Diazepam market is highly fragmented with
major players like Pfizer, F.Hoffmann-La Roche, Mylan, Teva Pharmaceutical
Industries, Roche, Merck KGaA, Sun Pharmaceutical Industries, Bausch
Health, AbbVie, Mayne Pharma, and Vintage Pharms., collectively
constituting a competitive market.
Request for FREE Sample Copy of This Research Report at: https://www.reportsanddata.com/sample-enquiry-form/2055
For the purpose of this report,
Reports and Data has segmented the Diazepam market on the basis of form of
medication, application, end user and region:
Form of Medication Outlook
(Revenue in Million USD; 2016–2026)
- Oral Solution
- Rectal Gel
- Injection
- Tablet
- 2 mg
- 5 mg
- 10mg
Application Outlook (Revenue
in Million USD; 2016–2026)
- Anxiety Disorders
- Alcohol Withdrawal
- Muscle Spasms
- Seizures
- Sedation
- Insomnia
End User Outlook (Revenue in
Million USD; 2016–2026)
- Geriatric
- Pediatric
- Adults
Regional Outlook (Revenue in
Million USD; 2016–2026)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of the Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
Make an Inquiry at: https://www.reportsanddata.com/make-enquiry-form/2055
No comments:
Post a Comment